TacticScaleWhat Avantor Does & How It Makes Money (AVTR)
Updated October 2026 · reflects Avantor's latest reported financials
Supplier of lab materials, equipment and services for life sciences. It earns revenue mainly from recurring sales of consumables and materials such as high-purity chemicals, reagents and single-use assemblies, plus sales of lab equipment and instruments.
How Avantor makes money
It earns revenue mainly from recurring sales of consumables and materials such as high-purity chemicals, reagents and single-use assemblies, plus sales of lab equipment and instruments. It also charges fees for services such as onsite lab management, procurement and sourcing, and scientific research support.
What Avantor does
Avantor, Inc., founded in 1904 and headquartered in Radnor, Pennsylvania, supplies products and services to the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East and Africa. Its range includes materials and consumables such as purity chemicals and reagents, formulated silicones, customized excipients, single-use assemblies, chromatography resins, clinical trial kits and fluid handling tips, along with equipment such as filtration and virus inactivation systems, incubators, analytical instruments, freezers and biosafety cabinets. In addition to products, Avantor provides onsite lab and production services, procurement and sourcing, biopharmaceutical material scale-up and development, and research support such as DNA extraction, bioreactor servicing, biorepository, compound management and cleanroom services. Much of this is consumed over and over in customers' research and manufacturing, so a large share of its sales tends to recur.
Products & services
- High-purity chemicals and reagents
- Lab products and consumables
- Customized single-use assemblies and excipients
- Process chromatography resins and columns
- Ultra-low-temperature freezers and biological safety cabinets
- Onsite lab and procurement services
What is Avantor worth?
On an owner-earnings DCF, Avantor's most-likely value is about $14 versus a recent price near $16 (12% above fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$8) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
⚠ High leverage — net debt is 7.4× annual cash flow. Net debt is subtracted from this fair value, but refinancing at higher rates, principal timing, and share dilution aren’t modeled — the equity can be worth far less if cash flow weakens.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Avient (AVNT) · Agilent Technologies (A) · Thermo Fisher Scientific (TMO) · Revvity (RVTY) · Bio-Rad Laboratories (BIO)